PNC Financial Services Group
ACIU icon

PNC Financial Services Group’s AC Immune ACIU Stock Holding History

PNC Financial Services Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75K Buy
+1,000
New +$3.1K ﹤0.01% 4491
2021
Q4 		– Sell
-1
Closed – – 4420
2021
Q3 		$0 Buy
+1
New +$7 ﹤0.01% 4279

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PNC Financial Services Group's ACIU Position: Q1 2026 in Review

PNC Financial Services Group opened a new position in AC Immune (ACIU) in Q1 2026: 1,000 shares worth $2.75K. The stake represents ﹤0.01% of the portfolio and ranks #4491 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in ACIU as recently as Q3 2021.

PNC Financial Services Group first reported a position in ACIU in Q3 2021 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • PNC Financial Services Group held 1,000 shares of AC Immune worth $2.75K as of Q1 2026.
  • AC Immune was a new PNC Financial Services Group position in Q1 2026.
  • AC Immune made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4491 holding.
  • PNC Financial Services Group first reported a position in AC Immune in Q3 2021 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.